Literature DB >> 13106198

Clinical assessment of tetra-sodium 2-methyl-1: 4-naphthohydroquinone diphosphate as a radiosensitiser in the radiotherapy of malignant tumours.

J S MITCHELL.   

Abstract

Entities:  

Keywords:  NEOPLASMS/therapy; RADIOTHERAPY; VITAMIN K/derivatives

Mesh：

Substances：

Year:  1953        PMID： 13106198      PMCID： PMC2007899          DOI： 10.1038/bjc.1953.30

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  Results of radiation therapy for bronchogenic carcinoma; a statistical analysis of 125 cases.

Authors:  B P ADELMAN
Journal:  Radiology       Date:  1952-09       Impact factor: 11.105

2.  The effect of tetra-sodium 2-methyl-1:4-naphthohydroquinione diphosphate (synkayvite) on a variety of malignant tumours in experimental animals.

Authors:  A GELLHORN; T GAGLIANO
Journal:  Br J Cancer       Date:  1950-03       Impact factor: 7.640

3.  Experiments on the mechanism of action of tetra-sodium 2-methyl-1 : 4. naphthohydroquinone diphosphate as a mitotic inhibitor and radiosensitiser, using the technique of tissue culture. Experimental methods and quantitative results.

Authors:  J S MITCHELL; I SIMON-REUSS
Journal:  Br J Cancer       Date:  1952-09       Impact factor: 7.640
  3 in total
  4 in total

1.  Cancer and the radiotherapist.

Authors:  A M JELLIFFE
Journal:  Postgrad Med J       Date:  1961-06       Impact factor: 2.401

2.  Protection by cysteine against the acute toxicity of a chemical radio-sensitizer (synkavit).

Authors:  A F PHILLIPS; D B CATER
Journal:  Br J Pharmacol Chemother       Date:  1956-06

3.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1954-08-14

4.  [Derivatives of 2-amino-1,4-naphthoquinone as carcinostatic agents].

Authors:  S Petersen; W Gauss; H Kiehne; L Jühling
Journal:  Z Krebsforsch       Date:  1969
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.